Pfizer's Move: Should You Reconsider BNTX Stock?
Pfizer's decision to offload its remaining shares in BioNTech (BNTX) has raised eyebrows. This move hints at a lack of faith in BioNTech's COVID-19 vaccine and its stock potential. BioNTech, once a profit powerhouse, is now facing significant losses. Its shares, though not cheap, reflect a company struggling to find solid ground. BioNTech's star product, the COVID-1...